P313 Impact of upadacitinib on the general clinical condition of patients with Crohn’s disease (CD): data from the randomised CELEST study
Main Authors: | Loftus, E, Rubin, D, Panes, J, Pugatch, D, Zhou, W, Goteti, S, Lacerda, A, Travis, S |
---|---|
Format: | Conference item |
Published: |
Oxford University Press
2019
|
Similar Items
-
Resolution of metastatic cutaneous Crohn's disease with upadacitinib monotherapy
by: Kevin M. Burningham, MD, et al.
Published: (2024-04-01) -
Symptomatic creatine phosphokinase elevation in a Crohn's disease patient caused by upadacitinib
by: Anna Schuitema, et al.
Published: (2024-01-01) -
Upadacitinib in a patient with Crohn’s disease with loss of response to ustekinumab: A case report
by: E.F. Coronado-Rivera, et al.
Published: (2024-07-01) -
Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
by: Leah A Johnston, et al.
Published: (2023-03-01) -
Entretien avec Celeste Arrington
by: Celeste Arrington, et al.
Published: (2023-12-01)